Medical Resources buys three centers

Article

Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition

Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition brings to 82 the number of centers operated by the company.

In other news, the company last month raised $26 million through an issue of senior notes to a group of insurance companies led by John Hancock Mutual Life Insurance. The Hackensack, NJ, company said it would use proceeds from the issue to fund acquisitions and for general corporate purposes. The placement brings the total amount that Medical Resources has raised this year through investment-grade senior note issues to $78 million.

In other Medical Resources news, the company acquired a controlling interest in a multimodality imaging center in midtown Manhattan. Medical Resources paid $1 million for the stake in the center, which is located within a state-of-the art medical suite to be opened by a private physician group this fall. The center is also the company's first joint venture with a physician practice management company.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.